|
|||||
|
Who to trust on vaccines? In 2009, The Federal Drug Advisory board (FDA) issued an advisory update on the H1N1 influenza virus in which it clearly identified five groups most at risk from death from swine flu. Leading those five groups was pregnant women. The CDC (Centre for Disease Control) advised: “A pregnant woman [...] Testing mouse model strains of the HSV-2 virus from both African and US sources, the Harvard research team discovered that vaccines were far more efficacious against the US strain than the African strain. [...] A study reinforces the difficulties in formulating a successful vaccine against CMV, but on a positive note, if CMV could be used as a viral vector in the development of vaccine against HIV, Herpes, Hepatitis C and other viruses affecting the immune system, then unlike other viral vectors which may be used only once (due to their detection and future elimination by killer T cells). CMV could be used repeatedly to stimulate an immune response. [...] Emory Institute of Drug Discovery has teamed up with biotechnology company Zirus Inc. in an effort to produce up-to-the-minute anti viral drugs to combat such diseases as HIV, Herpes and even the common cold virus. [...] By extracting and treating stem cells, the antiviral DNA can theoretically be delivered directly to the patient’s auto-immune system, bypassing drug administration. Cells would be taken from the patient’s bone marrow, and treated with anti-viral DNA in vitro, after which the stem cells would be re-injected into the patient. [...] Chelsea and Westminster Hospital, London, England is the scene for ground breaking patient trials of a vaccine designed to prevent the spread of genital herpes by infected individuals to their sexual partners. [...] Leading vaccine development company, Genocea Biosciences has announced its acquisition of licences from the University of Washington and Fred Hutchinson Cancer Research Center for 25 patents, issued and pending, relating to HSV-2 antigens. [...] Eight years ago, Glaxo SmithKline heralded new US research into a prophylactic genital herpes candidate vaccine. The trial, known as the HERPEVAC Trial for Women involved 7,550 women, aged 18 to 30 from across the US and the hopeful outcome of this ongoing trial will be a safe genital herpes vaccine. It would seem that as a result of the global recession, British-based GSK are laying off some 4,000 workers, half of them in the research and development field. One could then question the research staff cut impact on GSK research quality and validity. [...] With the help of a $400k grant from the National Institute of Health, Halford claims to have successfully changed the herpes simplex virus 2 by altering a gene known as ICPO, so that the virus no longer produces herpes symptoms. [...] Scientists discovered a new way for the body’s immune system to fight the virus responsible for cold sores: Type 1 herpes simplex (HSV-1). A group of virologists from the University of Montreal in partnership with American counterparts, have identified a cellular activity that detects and combats the herpes virus. [...] |
|
||||
|
Copyright © 2012 Herpes News - All Rights Reserved Bad Behavior has blocked 77 access attempts in the last 7 days. |
|||||
